Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
Open Life Sciences · 16.08.2024 · 19 (1)
DOI: 10.1515/biol-2022-0908 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Open Life Sciences, online erschienen am 16.08.2024. Verfasst von Chun Jiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The People's Hospital of SND, Suzhou, Jiangsu, 215129, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recent scientific investigations have revealed the intricate mechanisms underlying bone formation, emphasizing the essential role of long non-coding RNAs (lncRNAs) as critical regulators. This process, essential for skeletal strength and functionality, involves the transformation of mesenchymal stem cells into osteoblasts and subsequent deposition of bone matrix. lncRNAs, including HOX transcript antisense RNA (HOTAIR), metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), differentiation antagonizing non-coding RNA (DANCR), and maternally expressed gene 3 (MEG3), have emerged as prominent players in this regulatory network. HOTAIR modulates osteoblast differentiation by interacting with chromatin-modifying enzymes, while MALAT1 regulates osteogenic differentiation through microRNA interactions. DANCR collaborates with Runx2 to fine-tune osteoblast differentiation, and MEG3 orchestrates multiple signaling pathways crucial for bone formation. Moreover, other lncRNAs such as H19, lncRNA for enhancing osteogenesis 3, rhabdomyosarcoma 2-associated transcript, urothelial cancer associated 1, taurine up-regulated gene 1, and nuclear enriched abundant transcript 1 contribute to the complex regulatory network governing osteoblast activities. Understanding the precise roles of these lncRNAs offers promising avenues for developing innovative therapeutic strategies targeting bone-related disorders like osteoporosis. Overall, this review summarizes the pivotal role of lncRNAs in bone formation, highlighting their potential as targets for future research endeavors aimed at advancing therapeutic interventions in bone diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, The People's Hospital of SND, Suzhou, Jiangsu, 215129, China.
- Department of Spine Surgery, Shengli Oilfield Central Hospital, Dongying, Shandong, 257000, China.
- Department of Orthopedics, Sichuan Fifth People's Hospital, Chengdu, Sichuan, 610015, China.
ORCID-Profile: Yin Zhang
Zitieren
APA
Jiang, C., Wang, P., Tan, Z., & Zhang, Y. (2024). Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects. Open Life Sciences, 19(1). https://doi.org/10.1515/biol-2022-0908
Vancouver
Jiang C, Wang P, Tan Z, Zhang Y. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects. Open Life Sciences. 2024;19(1). doi:10.1515/biol-2022-0908
BibTeX
@article{Jiang2024,
author = {Jiang, Chun and Wang, Peng and Tan, ZhenWei and Zhang, Yin},
title = {Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects},
journal = {Open Life Sciences},
year = {2024},
volume = {19},
number = {1},
doi = {10.1515/biol-2022-0908}
}
EUVIMED